TransPrEP: Results from the Pilot Study of a Social Network-Based Intervention to Support PrEP Adherence Among Transgender Women in Lima, Peru.
Jesse L ClarkSari ReisnerAmaya Perez-BrumerLeyla HuertaHugo SanchezKathleen MoriartyMaria Mamani LuqueHideaki OkochiXimena SalazarMatthew MimiagaJorge SanchezMonica GandhiKenneth H MayerJavier R LamaPublished in: AIDS and behavior (2021)
We conducted a pilot randomized controlled trial of a social network-based intervention to promote PrEP adherence among transgender women (TW) in Lima, Peru. We enrolled 89 TW from six social networks and cluster-randomized them 1:1 to standard of care (n = 44) or the TransPrEP intervention (n = 45). Core workshops discussed strategies to support PrEP adherence and defined group adherence objectives. Maintenance workshops discussed participants' experiences taking PrEP and collective adherence goals. At 3-month follow-up, we evaluated 40 participants and obtained 29 hair samples for tenofovir level measurements. Though no significant differences were observed, 36.4% (4/11) of participants of TransPrEP participants and 10.0% (1/10) of control participants had tenofovir levels > 0.023 ng/mg, consistent with ≥ 4 doses per week. 81.8% (9/11) of intervention and 40.0% (4/10) of control participants had any detectable tenofovir in their hair. Pilot assessment of our network-based intervention suggested a trend towards improved PrEP adherence, measured objectively, for TW in Peru.
Keyphrases
- randomized controlled trial
- men who have sex with men
- study protocol
- healthcare
- hiv testing
- mental health
- glycemic control
- polycystic ovary syndrome
- type diabetes
- physical activity
- systematic review
- pregnant women
- placebo controlled
- pregnancy outcomes
- metabolic syndrome
- chronic pain
- phase iii
- pain management
- meta analyses
- phase ii